Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Francesca BridgeJulia BrothertonJim StankovichPaul G SanfilippoOlga G SkibinaKatherine BuzzardTomas KalincikAi-Lan NguyenKylie GuoMastura MonifC David WredeLouise RathLisa TaylorHelmut ButzkuevenVilija G JokubaitisAnneke Van Der WaltPublished in: Neurology (2024)
This study provides Class III evidence that highly active MS therapy compared with less active therapy increases the risk of developing cervical abnormalities among women with MS.